120 related articles for article (PubMed ID: 35487774)
1. The impact of distance to closest negative margin on survival after pelvic exenteration.
Martin AL; Sinha S; Peres LC; Hakam A; Chon HS; Hoffman MS; Shahzad MM; Wenham RM; Chern JY
Gynecol Oncol; 2022 Jun; 165(3):514-521. PubMed ID: 35487774
[TBL] [Abstract][Full Text] [Related]
2. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
3. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of pelvic exenteration for gynecologic malignancies.
Moolenaar LR; van Rangelrooij LE; van Poelgeest MIE; van Beurden M; van Driel WJ; van Lonkhuijzen LRCW; Mom CH; Zaal A
Gynecol Oncol; 2023 Apr; 171():114-120. PubMed ID: 36870097
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
[TBL] [Abstract][Full Text] [Related]
7. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
[TBL] [Abstract][Full Text] [Related]
8. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A
Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295
[TBL] [Abstract][Full Text] [Related]
9. Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
Graves S; Seagle BL; Strohl AE; Shahabi S; Nieves-Neira W
Int J Gynecol Cancer; 2017 Feb; 27(2):390-395. PubMed ID: 27984375
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer.
Simillis C; Baird DL; Kontovounisios C; Pawa N; Brown G; Rasheed S; Tekkis PP
Ann Surg; 2017 Feb; 265(2):291-299. PubMed ID: 27537531
[TBL] [Abstract][Full Text] [Related]
11. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
12. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma.
Viswanathan AN; Pinto AP; Schultz D; Berkowitz R; Crum CP
Gynecol Oncol; 2013 Sep; 130(3):545-9. PubMed ID: 23747330
[TBL] [Abstract][Full Text] [Related]
13. A Proposal to Redefine Close Surgical Margins in Squamous Cell Carcinoma of the Oral Tongue.
Zanoni DK; Migliacci JC; Xu B; Katabi N; Montero PH; Ganly I; Shah JP; Wong RJ; Ghossein RA; Patel SG
JAMA Otolaryngol Head Neck Surg; 2017 Jun; 143(6):555-560. PubMed ID: 28278337
[TBL] [Abstract][Full Text] [Related]
14. Analysis of long-term outcomes in 44 patients following pelvic exenteration due to cervical cancer.
Lewandowska A; Szubert S; Koper K; Koper A; Cwynar G; Wicherek L
World J Surg Oncol; 2020 Sep; 18(1):234. PubMed ID: 32878646
[TBL] [Abstract][Full Text] [Related]
15. Overall survival after pelvic exenteration for gynecologic malignancy.
Westin SN; Rallapalli V; Fellman B; Urbauer DL; Pal N; Frumovitz MM; Ramondetta LM; Bodurka DC; Ramirez PT; Soliman PT
Gynecol Oncol; 2014 Sep; 134(3):546-51. PubMed ID: 25014540
[TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis.
Valstad H; Eyjolfsdottir B; Wang Y; Kristensen GB; Skeie-Jensen T; Lindemann K
Eur J Surg Oncol; 2023 Sep; 49(9):106958. PubMed ID: 37349160
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
18. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
19. Outcomes following repeat exenteration for locally advanced pelvic malignancy.
Blake J; Koh CE; Steffens D; De Robles MS; Brown K; Lee P; Austin K; Solomon MJ
Colorectal Dis; 2021 Mar; 23(3):646-652. PubMed ID: 33058495
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of positive surgical margins for scalp angiosarcoma.
Kuan CH; Yang HW; Huang HF; Jyuhn-Hsiarn Lee L; Tseng TY; Hsieh JH; Cheng NC; Tai HC; Lai HS
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):217-225. PubMed ID: 32446755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
